ARAY

Accuray Incorporated [ARAY] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ARAY Stock Summary

Top 10 Correlated ETFs

ARAY


Top 10 Correlated Stocks

ARAY


In the News

12:47 29 Sep 2023 ARAY

Why Is Accuray (ARAY) Down 15.2% Since Last Earnings Report?

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?

02:36 29 Sep 2023 ARAY

Accuray Incorporated - Impressive Growth As Orders Expands

Accuray Incorporated has shown impressive growth in its share price and revenues, making it an attractive investment opportunity in the healthcare equipment market. The company is becoming a leader in the precision radiation therapy market and has a positive market outlook. ARAY's innovative radiosurgery and radiation therapy systems play a crucial role in cancer treatment and have a large market to tap into, particularly in China and Brazil.

10:55 29 Sep 2023 ARAY

Accuray's (ARAY) Treatment Options to be Boosted Post FDA's Nod

Accuray's (ARAY) latest regulatory approval is likely to improve breast cancer treatment.

10:02 29 Sep 2023 ARAY

New Strong Sell Stocks for August 11th

NGLOY, ARAY and BANR have been added to the Zacks Rank #5 (Strong Sell) List on August 11, 2023.

01:00 29 Sep 2023 ARAY

Accuray (ARAY) Q4 Earnings and Revenues Lag Estimates

Accuray (ARAY) reports a solid fiscal fourth quarter top line on the back of robust segmental performances.

09:58 29 Sep 2023 ARAY

Accuray (ARAY) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Accuray (ARAY) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

11:42 29 Sep 2023 ARAY

Accuray (ARAY) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about Accuray's (ARAY) solid product portfolio.

10:45 29 Sep 2023 ARAY

Accuray (ARAY) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Accuray (ARAY) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

07:45 29 Sep 2023 ARAY

Accuray (ARAY) Q3 Earnings and Revenues Beat Estimates

Accuray (ARAY) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.01 per share a year ago.

09:59 29 Sep 2023 ARAY

Here's Why You Should Retain Accuray (ARAY) Stock for Now

Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.

ARAY Financial details

Company Rating
Buy
Market Cap
260.79M
Income
-9.28M
Revenue
447.61M
Book val./share
0.56
Cash/share
0.93
Dividend
-
Dividend %
-
Employees
1.02K
Optionable
No
Shortable
Yes
Earnings
31 Oct 2023
P/E
-28.23
Forward P/E
-
PEG
-4.48
P/S
0.59
P/B
4.88
P/C
2.91
P/FCF
87.75
Quick Ratio
0.83
Current Ratio
1.7
Debt / Equity
3.82
LT Debt / Equity
3.64
-
-
EPS (TTM)
-0.09
EPS next Y
-
EPS next Q
-0.07
EPS this Y
68.33%
EPS next Y
-
EPS next 5Y
142.87%
EPS last 5Y
-12.44%
Revenue last 5Y
1.34%
Revenue Q/Q
0.2%
EPS Q/Q
-366%
-
-
-
-
SMA20
-
SMA50
-25%
SMA100
-25%
Inst Own
69.86%
Inst Trans
1.13%
ROA
-2%
ROE
-18%
ROC
-
Gross Margin
34%
Oper. Margin
-
Profit Margin
-2%
Payout
-
Shs Outstand
96.59M
Shs Float
86.7M
-
-
-
-
Target Price
7
52W Range
1.81-4.3
52W High
-32.25%
52W Low
+171%
RSI
41
Rel Volume
0.18
Avg Volume
745.99K
Volume
135.69K
Perf Week
0.37%
Perf Month
-6.55%
Perf Quarter
-10.86%
Perf Half Y
-4.91%
-
-
-
-
Beta
1.57054
-
-
Volatility
0.04%, 0.07%
Prev Close
-0.73%
Price
2.71
Change
-1.09%

ARAY Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric History 2019-06-302020-06-302021-06-302022-06-30 2023-06-30
Revenue per share
4.794.264.314.674.72
Net income per share
-0.190.04-0.07-0.06-0.1
Operating cash flow per share
-0.34-0.020.42-0.030.16
Free cash flow per share
-0.39-0.060.39-0.080.03
Cash per share
0.881.21.260.960.94
Book value per share
0.570.70.750.580.57
Tangible book value per share
-0.10.050.11-0.05-0.04
Share holders equity per share
0.570.70.750.580.57
Interest debt per share
22.672.352.412.16
Market cap
341.99M182.44M415.98M180.51M367.2M
Enterprise value
425.03M296.57M499.02M305.5M482.84M
P/E ratio
-20.8157.81-65.91-33.76-39.57
Price to sales ratio
0.820.481.050.420.82
POCF ratio
-11.54-124.210.8-75.2123.63
PFCF ratio
-10.07-35.1111.49-25.36125.54
P/B Ratio
6.862.916.043.396.84
PTB ratio
6.862.916.043.396.84
EV to sales
1.010.771.260.711.08
Enterprise value over EBITDA
729.0524.9922.4437.49202.7
EV to operating cash flow
-14.34-201.8912.96-127.2931.07
EV to free cash flow
-12.52-57.0713.79-42.93165.07
Earnings yield
-0.050.02-0.02-0.03-0.03
Free cash flow yield
-0.1-0.030.09-0.040.01
Debt to equity
3.213.532.94.023.82
Debt to assets
0.360.450.420.450.43
Net debt to EBITDA
142.459.623.7315.3448.54
Current ratio
1.791.961.831.681.7
Interest coverage
-0.660.240.940.320
Income quality
1.8-0.38-6.10.45-1.67
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.120.110.110.10.11
Research and developement to revenue
0.130.130.130.130.13
Intangibles to total assets
0.130.120.120.120.12
Capex to operating cash flow
0.152.54-0.061.97-0.81
Capex to revenue
-0.01-0.01-0.01-0.01-0.03
Capex to depreciation
-0.41-0.49-0.36-0.86-2.79
Stock based compensation to revenue
0.030.020.020.020.02
Graham number
1.550.741.070.871.12
ROIC
-0.050.010.070.020.01
Return on tangible assets
-0.040.01-0.01-0.01-0.02
Graham Net
-1.91-2.06-1.82-2.05-2.19
Working capital
151.89M174.37M160.41M142.03M139.4M
Tangible asset value
-8.58M4.41M10.45M-4.9M-4.23M
Net current asset value
-44.24M-70.66M-58.49M-68.77M-87.52M
Invested capital
3.213.532.94.023.82
Average receivables
88.94M100.74M87.48M89.9M84.61M
Average payables
24.63M26.34M21.3M25.4M32.54M
Average inventory
114.68M127.67M130.23M134.09M143.7M
Days sales outstanding
97.5285.478.6280.1860.98
Days payables outstanding
42.1336.2230.0142.3741.94
Days of inventory on hand
172.18210.69194.12192.34180.42
Receivables turnover
3.744.274.644.555.99
Payables turnover
8.6610.0812.168.618.7
Inventory turnover
2.121.731.881.92.02
ROE
-0.330.05-0.09-0.1-0.17
Capex per share
-0.05-0.04-0.03-0.05-0.13

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q4

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
Revenue per share
1.181.031.211.241.23
Net income per share
-0.04-0.06-0.020.01-0.03
Operating cash flow per share
-0.050-0.190.260.01
Free cash flow per share
-0.06-0.01-0.210.240.01
Cash per share
0.950.870.720.930.93
Book value per share
0.570.50.550.570.56
Tangible book value per share
-0.05-0.12-0.07-0.04-0.04
Share holders equity per share
0.570.50.550.570.56
Interest debt per share
2.332.222.222.162.14
Market cap
182.37M194.54M197.65M283.7M371.31M
Enterprise value
307.37M318.85M337.3M399.66M486.94M
P/E ratio
-13.21-8.93-26.37118.41-36.32
Price to sales ratio
1.662.021.722.43.14
POCF ratio
-39.274.23K-10.9711.52373.92
PFCF ratio
-30.19-158.68-10.1112.45373.92
P/B Ratio
3.434.143.825.196.92
PTB ratio
3.434.143.825.196.92
EV to sales
2.793.32.943.394.12
Enterprise value over EBITDA
150.08-146.13124.69172.57-1.07K
EV to operating cash flow
-66.196.93K-18.7216.23490.37
EV to free cash flow
-50.89-260.07-17.2517.54490.37
Earnings yield
-0.02-0.03-0.010-0.01
Free cash flow yield
-0.03-0.01-0.10.080
Debt to equity
4.024.374.013.753.82
Debt to assets
0.450.440.440.430.43
Net debt to EBITDA
61.03-56.9751.6350.07-253.03
Current ratio
1.681.741.821.791.7
Interest coverage
0.22-0.960.591.020
Income quality
1.35-0.019.6141.11-0.39
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.110.120.10.090.11
Research and developement to revenue
0.130.150.130.120.12
Intangibles to total assets
0.120.120.120.120.12
Capex to operating cash flow
0.3-27.650.09-0.070
Capex to revenue
-0.01-0.01-0.01-0.020
Capex to depreciation
-1.1-1.08-1.33-1.670
Stock based compensation to revenue
0.020.030.030.010.02
Graham number
0.690.810.490.280.58
ROIC
0.01-0.010.0100
Return on tangible assets
-0.01-0.0100-0.01
Graham Net
-2.03-2.18-2.16-2.08-2.16
Working capital
142.03M142.73M152.23M151.09M139.4M
Tangible asset value
-4.9M-10.88M-6.3M-3.36M-4.23M
Net current asset value
-68.77M-84.09M-80.08M-78.1M-87.52M
Invested capital
4.024.374.013.753.82
Average receivables
91.87M85.74M83.11M83.27M76.06M
Average payables
31.85M32.14M33.4M31.25M31.19M
Average inventory
139.89M147.44M154.14M153.12M147.87M
Days sales outstanding
77.2571.8569.9458.9756.89
Days payables outstanding
42.0947.942.4532.537.67
Days of inventory on hand
191.08221.92195.14170.81162.05
Receivables turnover
1.161.251.291.531.58
Payables turnover
2.141.882.122.772.39
Inventory turnover
0.470.410.460.530.56
ROE
-0.06-0.12-0.040.01-0.05
Capex per share
-0.02-0.01-0.02-0.020

ARAY Frequently Asked Questions

What is Accuray Incorporated stock symbol ?

Accuray Incorporated is a US stock , located in Sunnyvale of Ca and trading under the symbol ARAY

Is Accuray Incorporated buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $7. The lowest prediction is $7 and the highest is $7

What is ARAY stock prediction ?

What is Accuray Incorporated stock quote today ?

Accuray Incorporated stock price is $2.71 today.

Is Accuray Incorporated stock public?

Yes, Accuray Incorporated is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap